Literature DB >> 2541930

Allele-specific down-regulation of MHC class I antigens in Burkitt lymphoma lines.

M G Masucci1, N J Stam, S Torsteinsdottir, J J Neefjes, G Klein, H L Ploegh.   

Abstract

We have reported that Burkitt lymphomas (BL) that arise in HLA-A11 positive individuals are resistant to lysis by HLA-A11-specific and HLA-A11-restricted CTLs(10,11). Here we show that this phenomenon can be explained by a selective loss of the HLA-A11 polypeptide. The HLA-A11 negative phenotype is due to a regulatory phenomenon, rather than a structural defect, as proven by the ability to rescue expression of HLA-A11 in in vitro Epstein-Barr virus (EBV)-converted sublines of EBV negative BLs.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2541930     DOI： 10.1016/0008-8749(89)90207-4

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


  8 in total

Review 1.  Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis.

Authors:  D J Moss; I S Misko; T B Sculley; A Apolloni; R Khanna; S R Burrows
Journal:  Springer Semin Immunopathol       Date:  1991

2.  Search for the critical characteristics of phenotypically different B cell lines, Burkitt lymphoma cells and lymphoblastoid cell lines, which determine differences in their functional interaction with allogeneic lymphocytes.

Authors:  J Avila-Cariño; S Torsteinsdottir; B Ehlin-Henriksson; M G Masucci; E Klein
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.

Authors:  Federica Destro; Fabio Sforza; Mariaconcetta Sicurella; Diego Marescotti; Eleonora Gallerani; Anna Baldisserotto; Mauro Marastoni; Riccardo Gavioli
Journal:  Immunology       Date:  2011-02-22       Impact factor: 7.397

4.  Transcriptional regulation of the MHC class I HLA-A11 promoter by the zinc finger protein ZFX.

Authors:  M L'Haridon; P Paul; J G Xerri; H Dastot; C Dolliger; M Schmid; N de Angelis; L Grollet; F Sigaux; L Degos; C Gazin
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

Review 5.  Modulation of major histocompatibility complex antigen expression by viral infection.

Authors:  C R Rinaldo
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

6.  An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins.

Authors:  Q J Zhang; R Gavioli; G Klein; M G Masucci
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

7.  Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.

Authors:  Susan Prockop; Ekaterina Doubrovina; Stephanie Suser; Glenn Heller; Juliet Barker; Parastoo Dahi; Miguel A Perales; Esperanza Papadopoulos; Craig Sauter; Hugo Castro-Malaspina; Farid Boulad; Kevin J Curran; Sergio Giralt; Boglarka Gyurkocza; Katharine C Hsu; Ann Jakubowski; Alan M Hanash; Nancy A Kernan; Rachel Kobos; Guenther Koehne; Heather Landau; Doris Ponce; Barbara Spitzer; James W Young; Gerald Behr; Mark Dunphy; Sofia Haque; Julie Teruya-Feldstein; Maria Arcila; Christine Moung; Susan Hsu; Aisha Hasan; Richard J O'Reilly
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

8.  Epstein-Barr Virus and the Human Leukocyte Antigen Complex.

Authors:  Qingxue Li; Jeffrey I Cohen
Journal:  Curr Clin Microbiol Rep       Date:  2019-07-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.